CYP3A4 and stroke disorder: [6], 12 (2.3%) patients with a stroke or systemic embolism and 121 (1.2%) event-free matched controls were taking apixaban and one P-gp/CYP3A4 inducer for a resulting adjusted OR of 1.99 (95% CI, 1.10-3.63).